Inventor
SAM PHILIP HEYWOOD
Inventor
GB
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides43%
A61KPreparations for medical, dental or toiletry purposes24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations19%
C07CAcyclic or carbocyclic compounds5%
C12NMicroorganisms or enzymes5%
Y02ATechnologies for adaptation to climate change5%
PatentTitleYear
12,570,738Multi-specific antibody with binding specificity for human IL-13 and IL-17202612,516,106Method for protein purification202612,428,497Multispecific antibody constructs202511,834,514Method for increasing the percentage of monomeric antibody Fab-dsFv multimeric species202311,786,593Method of monomerisation of recombinant antibody molecules202311,466,076Binding domain or antibody specific to a human serum albumin (HSA)202211,427,650Dual specificity antibody fusions202211,401,349Single linker FabFv antibodies and methods of producing same202211,345,760Multispecific antibody constructs2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to UCB Biopharma SRL (9)· patent assignee history
2022Patents assigned to UCB BIOPHARMA SPRL (2)· patent assignee history
2022Patents assigned to UCB PHARMA SA (1)· patent assignee history
2022–2026Based in GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UCB Biopharma SRL | 9 | 2022–2026 |
| UCB BIOPHARMA SPRL | 2 | 2022 |
| UCB PHARMA SA | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| GB | 9 | 2022–2026 |